Bluebird, winding down in Europe, withdraws another rare disease gene therapy

Submitted by admin on October 21, 2021 - 11:17pm

Source:

BioPharma Dive

News Tags:

Bluebird Bio

gene therapy

Europe

Skysona

cerebral adrenoleukodystrophy

Headline:

Bluebird, winding down in Europe, withdraws another rare disease gene therapy

snippet:

Bluebird bio on Thursday said it will withdraw from market a rare disease gene therapy recently approved in Europe as the company winds down operations there.

Search form

You are here

Bluebird, winding down in Europe, withdraws another rare disease gene therapy

Bluebird, winding down in Europe, withdraws another rare disease gene therapy